Evaluation of ⁶⁴Cu-Based Radiopharmaceuticals that Target Aβ Peptide Aggregates as Diagnostic Tools for Alzheimer's Disease

Keyphrases

• Diagnostic Tool 100%
• Alzheimer's Disease 100%
• Positron Emission Tomography 100%
• Transgenic 100%
• Alzheimer's Disease Model 100%
• Imaging Agents 100%
• Radionuclides 100%
• Radiopharmaceuticals 100%
• Diagnostic Agents 100%
• Peptide Aggregates 100%
• Wild Mice 50%
• Amyloid Plaques 50%
• Alzheimer's Disease Patient 50%
• Clinical Application 50%
• Amyloid beta 50%
• Imaging Studies 50%
• Biodistribution Studies 50%
• Short Half-life 50%
• MicroPET Imaging 50%
• Bifunctional Chelator 50%
• Rapid Clearance 50%
• Alzheimer's Disease Diagnosis 50%
• Brain Waste Clearance 50%
• Mouse Brain Section 50%

Medicine and Dentistry

• Alzheimer's Disease 100%
• Copper 64 100%
• Radiopharmaceutical 100%
• Positron Emission Tomography 33%
• Imaging Agent 33%
• Radioisotope 33%
• Diagnostic Agent 33%
• In Vitro 16%
• Amyloid Plaque 16%
• Fluorine-18 16%
• Carbon 11 16%
• Biodistribution 16%
• Amyloid Beta 16%
• Chelating Agent 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Alzheimer's Disease 100%
• Copper 64 100%
• Radioisotope 33%
• Diagnostic Agent 33%
• Wild Type Mouse 16%
• Carbon 11 16%
• Biodistribution 16%
• Chelating Agent 16%
• Fluorine 18 16%
• Amyloid Plaque 16%
• Lead Compound 16%
• Amyloid Protein 16%